Bausch Health (TSX:BHC) Accounts Payable : C$890 Mil (As of Mar. 2025)

View and export this data going back to 1987. Start your Free Trial

What is Bausch Health Accounts Payable?

Bausch Health's Accounts Payable for the quarter that ended in Mar. 2025 was C$890 Mil.

Bausch Health's quarterly Accounts Payable increased from Sep. 2024 (C$904 Mil) to Dec. 2024 (C$935 Mil) but then declined from Dec. 2024 (C$935 Mil) to Mar. 2025 (C$890 Mil).

Bausch Health's annual Accounts Payable increased from Dec. 2022 (C$708 Mil) to Dec. 2023 (C$965 Mil) but then declined from Dec. 2023 (C$965 Mil) to Dec. 2024 (C$935 Mil).

Bausch Health Accounts Payable Historical Data

The historical data trend for Bausch Health's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Accounts Payable Chart

Bausch Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

Get a 7-Day Free Trial

431.66

520.96

707.78

964.61

934.60

Bausch Health Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable	Get a 7-Day Free Trial															869.01	793.52	903.52	934.60	890.07

Bausch Health Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Bausch Health Accounts Payable Related Terms

Thank you for viewing the detailed overview of Bausch Health's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

BHC:USA BVF:Germany BVF:Germany

Address

2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8

Website

https://www.bauschhealth.com

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Executives

Seana Lynne Carson	Senior Officer
Joseph Papa	Director, Senior Officer
Andrew Charles Von Eschenbach	Director
Robert Allen Spurr	Senior Officer
Joseph Gordon	Senior Officer
Steven Daniel Miller	Director
Richard Urbain De Schutter	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Osama Eldessouky	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Amy Wechsler	Director
William Douglas Humphries	Senior Officer
John Paulson	Director
Thomas Ross Sr.	Director
Christina Ackermann	Senior Officer
Paul Herendeen	Senior Officer